Results 21 to 30 of about 3,650 (207)

The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care: A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic. [PDF]

Obstet Gynecol, 2021
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, health care professionals have made swift accommodations to provide consistent and safe care, including emphasizing remote access to allow physical distancing.
Burlando AM, Flynn AN, Gutman S, McAllister A, Roe AH, Schreiber CA, Sonalkar S.   +6 more
europepmc   +2 more sources

Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients

National Journal of Physiology, Pharmacy and Pharmacology, 2023
Background: Contraception is the intentional use of artificial methods or other techniques to prevent pregnancy as a consequence of sexual intercourse. Progesterone only injectables are highly effective in preventing in pregnancy as they do not rely on ...
Jayun M Joshi, Harsh M Joshi, Hetal Patel, Param S Patel   +3 more
doaj   +1 more source

The effect of Vigna unguiculata on the estrogen receptor-α expression and the endometrial thickness in rats treated with depot medroxyprogesterone acetate (DMPA)

Healthcare in Low-resource Settings, 2023
Depot medroxyprogesterone acetate (DMPA) is a contraceptive method that prevents ovulation and reduces endometrial thickness. This study aimed to investigate the influence of Vigna unguiculata (VU) on estrogen receptor-α expression and endometrial ...
Rizki Fitrianingtyas, Indah Christiana, Ririn Handayani, Ernawati Anggraeni, Zaida Mauludiyah, Sholihatil Hidayati   +5 more
doaj   +1 more source

Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma. [PDF]

Obstet Gynecol, 2022
OBJECTIVE: Investigate the association between use of depot medroxyprogesterone acetate (DMPA) (an injectable progestin-only contraceptive) and leiomyoma development.
Harmon QE, Patchel SA, Zhao S, Umbach DM, Cooper TE, Baird DD.   +5 more
europepmc   +2 more sources

Contraceptive effectiveness, pharmacokinetics, and safety of Sayana® Press when injected every four months: a multicenter phase 3 trial

EClinicalMedicine, 2022
Summary: Background: Sayana Press® is a 3-monthly contraceptive injection approved by regulatory agencies in more than 40 countries worldwide. Existing effectiveness and pharmacokinetics (PK) data suggest that high contraceptive efficacy may be ...
Jennifer Deese, Vivian Brache, Luis Bahamondes, Abril Salinas, Aidelis Jorge, Nelio Veiga, Jr, Rachael Fuchs, Ashley Miller, Doug Taylor, Vera Halpern, Laneta Dorflinger   +10 more
doaj   +1 more source

Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa

Frontiers in Reproductive Health, 2021
Introduction: Whether intramuscular depot medroxyprogesterone acetate (DMPA-IM) and norethisterone enanthate (NET-EN) have a differential impact on the incidence of sexually transmitted infection (STI) remains unclear.
Lisa M. Noguchi, Jeanne M. Marrazzo, Barbara Richardson, Sharon L. Hillier, Jennifer E. Balkus, Thesla Palanee-Phillips, Gonasagrie Nair, Ravindre Panchia, Jeanna Piper, Kailazarid Gomez, Gita Ramjee, Z. Mike Chirenje   +11 more
doaj   +1 more source

Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate [PDF]

Journal of Midwifery & Reproductive Health, 2017
Background & aim: Sexual health is an essential element of quality of life, affecting both physical and psychological domains. Hormones used in contraceptive methods have contradictory effects on sexual function. In this study, we aimed to compare sexual
Nourossadat Kariman, Zohre Sheikhan, Masoumeh Simbar, Alireza Zahiroddin, Alireza Akbarzadeh Bahgban   +4 more
doaj   +1 more source

Epidemiological profile and effectiveness of immediate postpartum contraception in Brazilian women

Frontiers in Global Women's Health, 2023
PurposeTo determine the epidemiological profile of women who inserted copper intrauterine device (Cu-IUD), subdermal etonogestrel implant (ENG), tubal ligation (TL), depot medroxyprogesterone acetate (DMPA) or did not choose a contraceptive method (NCM ...
Marcelo Luis Steiner, Julia Lorenzini Mendes, Rodolfo Strufaldi, Monica Carneiro, Silvana Aparecida Giovanelli, Mariliza Henrique da Silva   +5 more
doaj   +1 more source

Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility [PDF]

, 2017
Depot-medroxyprogesterone acetate is a commonly used injectable contraceptive that has been associated with an increased risk of HIV acquisition. This study compares effects of depot-medroxyprogesterone acetate on immune parameters from several upper ...
Seidman, D, Greenblatt, RM, Averbach, S, Smith-McCune, KK, Critchfield, JW, Shacklett, BL, Shanmugasundaram, U, Giudice, LC, Hilton, JF   +8 more
core   +1 more source

Bone Mineral Density Among Long-term Users of Hormonal Contraception (Contraception and Bone Mineral Density) [PDF]

Al-Azhar International Medical Journal
Background: Hormonal contraceptives that involve steroids have a high success rate and are commonly used. The use of these contraceptives can have positive and negative effects on health, including bone health.
Hanaa Abd El Hameed El Ebeisy, Nahed Ezzat Mahmoud, Hanaa Taha Kandeel, Shaimaa Mahmoud Saad El Tawwab   +3 more
doaj   +1 more source